Latest Headlines
China-made CNBG vaccine can protect against different COVID-19 variants
  ·  2021-01-21  ·   Source: Xinhua News Agency

The China-made China National Biotec Group (CNBG) COVID-19 vaccine is broad-spectrum and can cross-neutralize different coronavirus strains, said a senior CNBG executive at a press conference on January 20.

Zhang Yuntao, vice president of CNBG, affiliated to Sinopharm, said the company had collected coronaviruses found in other countries that were attainable at the end of 2020 and conducted relevant tests.

Test results at the time showed the vaccine could provide extensive protection against strains from elsewhere in the world, said Zhang.

"However, we have observed reports of some new variants from countries including South Africa, Britain and Nigeria since that time," said Zhang, noting that the company is paying close attention to changes and will continue to carry out relevant cross-neutralization tests.

China
Opinion
World
Business
Lifestyle
Video
Multimedia
ChinAfrica
China Focus
Documents
Special Reports
 
About Us
Contact Us
Advertise with Us
Subscribe
Partners: China.org.cn   |   China Today   |   China Pictorial   |   People's Daily Online   |   Women of China   |   Xinhua News Agency   |   China Daily
CGTN   |   China Tibet Online   |   China Radio International   |   Global Times   |   Qiushi
Copyright Beijing Review All rights reserved 京ICP备08005356号 京公网安备110102005860